ClassID:

95260

C07D405/12 - page 17 - CPC Classification

Classification description:

Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#4801
20120328569
2012-12-27

INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE

#4802
20120322823
2012-12-20

Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof

#4803
20120322807
2012-12-20

STAT3/5 ACTIVATION INHIBITOR

#4804
20120322801
2012-12-20

Heterocyclic amides as rock inhibitors

#4805
20120322798
2012-12-20

Modulators of ATP-binding cassette transporters

#4806
20120322795
2012-12-20

Biarylamide inhibitors of leukotriene production

#4807
20120322787
2012-12-20

2-acylaminopropoanol-type glucosylceramide synthase inhibitors

#4808
20120322785
2012-12-20

Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof

#4809
20120322755
2012-12-20

Cytosine analogue, a method of preparation of a cytosine analogue, a DNA methyltransferase 1 inhibitor, a method for DNA methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal DNA methylation

#4810
20120319091
2012-12-20

AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME

#4811
20120316170
2012-12-13

Imidazole derivative

#4812
20120316167
2012-12-13

Secondary 8-hydroxyquinoline-7-carboxamide derivatives

#4813
20120316150
2012-12-13

AMIDE COMPOUNDS USEFUL IN THERAPY

#4814
20120316147
2012-12-13

Pyridine derivatives as agonists of the CB2 receptor

#4815
20120316135
2012-12-13

Compounds for inhibiting cell proliferation in EGFR-driven cancers

#4816
20120316126
2012-12-13

Compounds for the Treatment of Hepatitis C

#4817
20120315247
2012-12-13

Compounds comprising a spiro-ring

#4818
20120313041
2012-12-13

Four-ring compound having a plurality of CFO bonding groups, liquid crystal composition and liquid crystal display device

#4819
20120309777
2012-12-06

Substituted 2-imidazolidones and analogs

#4820
20120309769
2012-12-06

N-benzylindole modulators of PPARG

#4821
20120309760
2012-12-06

Piperazine compound having a PGDS inhibitory effect

#4822
20120309758
2012-12-06

Modulators of ATP-Binding Cassette transporters

#4823
20120309743
2012-12-06

Thiolactams and uses thereof

#4824
20120309738
2012-12-06

Compounds

#4825
20120309736
2012-12-06

Cyclic benzimidazole derivatives useful as anti-diabetic agents

#4826
20120309673
2012-12-06

Cysteine protease inhibitors

#4827
20120308587
2012-12-06

Neprilysin inhibitors

#4828
20120302757
2012-11-29

Synthetic intermediate of oxazole compound and method for producing the same

#4829
20120302748
2012-11-29

TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS

#4830
20120302620
2012-11-29

Pyrone-indole derivatives and process for their preparation

#4831
20120302617
2012-11-29

Phenyl and benzodioxinyl substituted indazoles derivatives

#4832
20120302609
2012-11-29

Pyrazolines for the Modulation of PKM2

#4833
20120302594
2012-11-29

Quaternary opioid carboxamides

#4834
20120302566
2012-11-29

INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS

#4835
20120302551
2012-11-29

THIOLACTAMS AND USES THEREOF

#4836
20120302545
2012-11-29

Method of using PI3K and MEK modulators

#4837
20120302541
2012-11-29

4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators

#4838
20120302539
2012-11-29

Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof

#4839
20120302531
2012-11-29

Beta-2-adrenoreceptor agonists

#4840
20120295938
2012-11-22

Ethers, secondary amines and derivatives thereof as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto

#4841
20120295920
2012-11-22

5-amino-4-hydroxypentoyl amides

#4842
20120295889
2012-11-22

3-arylamino pyridine derivatives

#4843
20120295856
2012-11-22

FREDERICAMYCIN DERIVATIVES

#4844
20120289718
2012-11-15

Compounds useful in the synthesis of halichondrin B analogs

#4845
20120289697
2012-11-15

Sulfonic acid derivative compound and novel naphthalic acid derivative compound

#4846
20120289522
2012-11-15

Compounds as lysophosphatidic acid receptor antagonists

#4847
20120289510
2012-11-15

Benzyl amines, a process for their production and their use as anti-inflammatory agents

#4848
20120289500
2012-11-15

Potassium channel modulators

#4849
20120289493
2012-11-15

Fused heterocyclic compounds as ion channel modulators

#4850
20120289484
2012-11-15

Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same

#4851
20120288501
2012-11-15

SUBSTITUTED BENZAZOLES AND METHODS OF THEIR USE AS INHIBITORS OF RAF KINASE

#4852
20120284004
2012-11-08

INVERTEBRATE ACETYLCHOLINESTERASE INHIBITORS

#4853
20120283432
2012-11-08

Use of rylene derivatives as photosensitizers in solar cells

#4854
20120283305
2012-11-08

Cysteine protease inhibitors

#4855
20120283301
2012-11-08

S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptase

#4856
20120283294
2012-11-08

CO-CRYSTAL OF 4-FURAN-2(5H)-ONE WITH BENZOIC ACID AND USE THEREOF AS PESTICIDE

#4857
20120283243
2012-11-08

Spiroindoline modulators of muscarinic receptors

#4858
20120283242
2012-11-08

Di-substituted pyridine derivatives as anticancers

#4859
20120277268
2012-11-01

Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

#4860
20120277259
2012-11-01

SUBSTITUTED BENZOFUSED DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS

#4861
20120277232
2012-11-01

Pyridine and pyrazine derivative for the treatment of CF

#4862
20120277231
2012-11-01

Quinolinyloxyphenylsulfonamides

#4863
20120277208
2012-11-01

BENZAMIDE COMPOUND

#4864
20120277190
2012-11-01

PRODRUGS OF COMPOUNDS THAT INHIBIT TRPV1 RECEPTOR

#4865
20120270904
2012-10-25

CO-CRYSTAL OF 4-FURAN-2(5H)-ONE WITH OXALIC ACID AND USE THEREOF AS PESTICIDE

#4866
20120270877
2012-10-25

IRE-1α inhibitors

#4867
20120270873
2012-10-25

Adamantyl diamide derivatives and uses of same

#4868
20120270869
2012-10-25

Pyridyl derivatives as CFTR modulators

#4869
20120270867
2012-10-25

(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors

#4870
20120270865
2012-10-25

Heterocyclic compound

#4871
20120270863
2012-10-25

FUSED RING ANALOGUES OF ANTI-FIBROTIC AGENTS

#4872
20120270861
2012-10-25

Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto

#4873
20120270318
2012-10-25

Ion channel modulators and methods of use

#4874
20120270203
2012-10-25

Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect

#4875
20120264764
2012-10-18

Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

#4876
20120264755
2012-10-18

PYRIDINYL DERIVATIVES AS INHIBITORS OF ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE

#4877
20120264737
2012-10-18

Heterocyclic modulators of lipid synthesis

#4878
20120264736
2012-10-18

Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors

#4879
20120264734
2012-10-18

Aryl- or heteroaryl-substituted benzene compounds

#4880
20120263659
2012-10-18

Use of physiological cooling active ingredients, and agents containing such active ingredients

#4881
20120259123
2012-10-11

AMINOPYRIDINE COMPOUND

#4882
20120259111
2012-10-11

Seven-membered ring compound and pharmaceutical use therefor

#4883
20120258975
2012-10-11

Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof

#4884
20120258947
2012-10-11

Substituted 6-amino-nicotinamides as KCNQ2/3 modulators

#4885
20120258946
2012-10-11

Substituted phenylureas and phenylamides as vanilloid receptor ligands

#4886
20120253039
2012-10-04

Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds

#4887
20120252864
2012-10-04

Substituted isoindoline-1,3-dione derivatives

#4888
20120252853
2012-10-04

Positive allosteric modulators of nicotinic acetylcholine receptor

#4889
20120252814
2012-10-04

Glucokinase activators

#4890
20120252809
2012-10-04

Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals

#4891
20120252808
2012-10-04

Quinoline amide M1 receptor positive allosteric modulators

#4892
20120252770
2012-10-04

Chemical Compounds 572

#4893
20120252766
2012-10-04

CO-CRYSTAL OF 4-FURAN-2(5H)-ONE WITH SALICYLIC ACID AND USE THEREOF AS PESTICIDE

#4894
20120245181
2012-09-27

Opioid receptor ligands and methods of using and making same

#4895
20120245124
2012-09-27

TRPV3 modulators

#4896
20120238750
2012-09-20

AROMATIC COMPOUND

#4897
20120238740
2012-09-20

NON-POLAR AND POLAR LEAVING GROUPS

#4898
20120238578
2012-09-20

Compositions useful as inhibitors of voltage-gated sodium channels

#4899
20120238572
2012-09-20

Use of substituted quinazoline compounds in treating age-related macular degeneration

#4900
20120238563
2012-09-20

NOVEL UNSATURATED TETRACYCLIC TETRAHYDROFURAN DERIVATIVES

#4901
20120238550
2012-09-20

Compound

#4902
20120238549
2012-09-20

Nuclear Hormone Receptor Modulators

#4903
20120238540
2012-09-20

AMINO-PYRIMIDINE COMPOUNDS AS INHIBITORS OF IKK EPSILON AND/OR TBK1

#4904
20120237961
2012-09-20

Labelling of fusion proteins with synthetic probes

#4905
20120237591
2012-09-20

Modified drugs for use in liposomal nanoparticles

#4906
20120232265
2012-09-13

1,2-disubstituted heterocyclic compounds

#4907
20120232112
2012-09-13

Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals

#4908
20120232096
2012-09-13

BENZOFURAN DERIVATIVES

#4909
20120232095
2012-09-13

BENZOFURAN DERIVATIVES

#4910
20120232083
2012-09-13

Fluoro-pyridinone derivatives useful as antibacterial agents

#4911
20120232070
2012-09-13

Use of Indole Derivatives as Nurr-1 Activators for the Application Thereof as a Medicament for the Treatment of Parkinson's Disease

#4912
20120232068
2012-09-13

Quinazolines as potassium ion channel inhibitors

#4913
20120232063
2012-09-13

2-aminoindole compounds and methods for the treatment of malaria

#4914
20120232059
2012-09-13

Modulators of ATP-Binding Cassette Transporters

#4915
20120232058
2012-09-13

SUBSTITUTED PYRIDINE DERIVATIVES AND THEIR MEDICAL USE

#4916
20120232055
2012-09-13

Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors

#4917
20120232053
2012-09-13

Quaternary ammonium compounds useful as muscarinic receptor antagonists

#4918
20120232052
2012-09-13

Aryl carboxamide derivatives as TTX-S blockers

#4919
20120232051
2012-09-13

3-amino-pyridines as GPBAR1 agonists

#4920
20120232039
2012-09-13

Primary amine diazeniumdiolate heterocyclic derivatives

#4921
20120232033
2012-09-13

Amines or amino alcohols as GLYT1 inhibitors

#4922
20120232028
2012-09-13

Bicyclic compound, production and use thereof

#4923
20120231998
2012-09-13

Organic compounds and their uses

#4924
20120230984
2012-09-13

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

#4925
20120225909
2012-09-06

INDAZOLE ANALOG

#4926
20120225908
2012-09-06

Hydroxyl compounds and compositions for cholesterol management and related uses

#4927
20120225906
2012-09-06

Piperidine renin inhibitors

#4928
20120225883
2012-09-06

Compounds for inflammation and immune-related uses

#4929
20120225867
2012-09-06

Androgen receptor modulating compounds

#4930
20120225859
2012-09-06

Pyrimidine derivatives used as PI-3 kinase inhibitors

#4931
20120225854
2012-09-06

Compounds that interact with glucokinase regulatory protein for the treatment of diabetes

#4932
20120225838
2012-09-06

Anti-tumor effect potentiator

#4933
20120225788
2012-09-06

Topoisomerase binding probe and method of use

#4934
20120225782
2012-09-06

Pesticides

#4935
20120225002
2012-09-06

PREPARATION OF 11C METHYL IODIDE

#4936
20120220629
2012-08-30

Asymmetric ureas and medical uses thereof

#4937
20120220592
2012-08-30

2-phenylethylamino derivatives as calcium and/or sodium channel modulators

#4938
20120220588
2012-08-30

Quinazoline compounds

#4939
20120214990
2012-08-23

Quinolinones and quinoxalinones as antibacterial composition

#4940
20120214822
2012-08-23

N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] ethoxy]phenyl] cyclopropyl] amino]-2-oxo-1 (2H)-pyrazinyl]-4-methyl-benzamide, or pharmaceutically acceptable salts thereof and their uses

#4941
20120214817
2012-08-23

Urotensin II receptor antagonists

#4942
20120214809
2012-08-23

Aminoindane compounds and use thereof in treating pain

#4943
20120214798
2012-08-23

Novel Ethanediamone Hepcidine Antagonists

#4944
20120214789
2012-08-23

Tetrazole-substituted arylamides as P2Xand P2Xantagonists

#4945
20120214786
2012-08-23

3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents

#4946
20120214785
2012-08-23

Compounds, pharmaceutical compositions and uses thereof

#4947
20120214770
2012-08-23

Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors

#4948
20120214735
2012-08-23

Acetamide derivatives as glucokinase activators, their process and medicinal applications

#4949
20120213806
2012-08-23

Neprilysin inhibitors

#4950
20120213795
2012-08-23

Compositions and methods for inhibition of the JAK pathway

#4951
20120213791
2012-08-23

3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators

#4952
20120209012
2012-08-16

Compounds, compositions and methods

#4953
20120208807
2012-08-16

TOFA analogs useful in treating dermatological disorders or conditions

#4954
20120208803
2012-08-16

Pyrrolidine derivatives as NK2 receptor antagonists

#4955
20120208790
2012-08-16

Ion channel modulators and methods of use

#4956
20120207769
2012-08-16

Inhibitors of IAP

#4957
20120203006
2012-08-09

Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

#4958
20120202814
2012-08-09

COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF

#4959
20120202813
2012-08-09

Triazole compounds that modulate HSP90 activity

#4960
20120202802
2012-08-09

Spirocyclic compounds as modulators of chemokine receptor activity

#4961
20120202756
2012-08-09

USE OF PRODRUGS TO AVOID GI MEDIATED ADVERSE EVENTS

#4962
20120202687
2012-08-09

Pesticidal compositions and processes related thereto

#4963
20120201783
2012-08-09

Compounds for the treatment of hepatitis C

#4964
20120201763
2012-08-09

Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof

#4965
20120197027
2012-08-02

Quinazoline derivatives as angiogenesis inhibitors

#4966
20120197015
2012-08-02

EPOXYCARBOXAMIDE COMPOUND, AZIDE COMPOUND, AND AMINO ALCOHOL COMPOUND, AND PROCESS FOR PREPARING a-KETO AMIDE COMPOUND USING THEM

#4967
20120196916
2012-08-02

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

#4968
20120196902
2012-08-02

Sulfoximines as kinase inhibitors

#4969
20120196897
2012-08-02

NEW COMPOUNDS

#4970
20120196885
2012-08-02

Histone deacetylase inhibitors based simultaneously on trisubstituted 1-pyrroles and aromatic and heteroaromatic spacers

#4971
20120196857
2012-08-02

Modulators of muscarinic receptors

#4972
20120196851
2012-08-02

Wnt pathway antagonists

#4973
20120196824
2012-08-02

THERAPEUTIC AGENT FOR CEREBRAL INFARCTION

#4974
20120196377
2012-08-02

Fluorescent molecule and method for detecting target nucleic acid

#4975
20120190856
2012-07-26

Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

#4976
20120190694
2012-07-26

SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS

#4977
20120190639
2012-07-26

TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS

#4978
20120190551
2012-07-26

Arylalkyl esters of 4-amino-6-(substituted phenyl)-picolinates and 6-amino-2-(substituted phenyl)-pyrimidinecarboxylates and their use as selective herbicides for crops

#4979
20120190543
2012-07-26

Pesticidal compositions

#4980
20120190035
2012-07-26

Detection of disease related genes

#4981
20120189614
2012-07-26

Inhibitors of filovirus entry into host cells

#4982
20120184728
2012-07-19

Compound amycolose derivative, method for producing the same, and use of the same

#4983
20120184550
2012-07-19

Substituted nicotinamides as KCNQ2/3 modulators

#4984
20120184520
2012-07-19

Glycine compound

#4985
20120183974
2012-07-19

Screening method for enzyme inhibitors

#4986
20120178781
2012-07-12

KAPPA OPIOID RECEPTOR LIGANDS

#4987
20120178762
2012-07-12

COMPOSITIONS OF AZIMILIDE DIHYDROCHLORIDE

#4988
20120178756
2012-07-12

Compounds useful as inhibitors of ATR kinase

#4989
20120178755
2012-07-12

Cyanoisoquinoline compounds and methods of use thereof

#4990
20120178713
2012-07-12

Piperidine and piperazine phenyl sulphonamides as modulators of ion channels

#4991
20120175600
2012-07-12

Aromatic amine derivative, and organic electroluminescent element

#4992
20120172374
2012-07-05

Tubulin inhibitors and methods of using the same

#4993
20120172369
2012-07-05

INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE

#4994
20120172351
2012-07-05

NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF

#4995
20120172337
2012-07-05

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#4996
20120165519
2012-06-28

Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors

#4997
20120165347
2012-06-28

Compounds and their use as BACE inhibitors

#4998
20120165344
2012-06-28

Compounds for the treatment of hepatitis C

#4999
20120165343
2012-06-28

Glucagon receptor modulators

#5000
20120165339
2012-06-28

CYCLOPROPANE DERIVATIVES

#5001
20120165338
2012-06-28

Biaryl amide derivatives

#5002
20120165322
2012-06-28

Rho kinase inhibitors

#5003
20120165319
2012-06-28

INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME

#5004
20120165318
2012-06-28

Heterocyclic compounds for the inhibition of PASK

#5005
20120165305
2012-06-28

Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

#5006
20120164102
2012-06-28

Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof

#5007
20120157498
2012-06-21

Substituted enaminocarbonyl compounds

#5008
20120157487
2012-06-21

Sulfur derivatives as chemokine receptor modulators

#5009
20120157463
2012-06-21

Chromone derivatives, a process for their preparation and their therapeutic applications

#5010
20120157454
2012-06-21

Isoquinolin-1 (2H)-one derivatives as PARP-1 inhibitors

#5011
20120157444
2012-06-21

1,2-bis-sulfonamide derivatives as chemokine receptor modulators

#5012
20120157437
2012-06-21

VLA-4 INHIBITORY DRUG

#5013
20120157433
2012-06-21

Heteroaryl Compounds as Kinase Inhibitors

#5014
20120157431
2012-06-21

Pyrimidine sulphonamide derivatives as chemokine receptor modulators

#5015
20120157413
2012-06-21

Phosphorous derivatives as chemokine receptor modulators

#5016
20120157383
2012-06-21

Neprilysin inhibitors

#5017
20120156219
2012-06-21

NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF

#5018
20120149735
2012-06-14

1,4-Dihydropyridine Derivatives and Their Uses

#5019
20120149732
2012-06-14

MULTIFUNCTIONAL LINKERS AND METHODS FOR THE USE THEREOF

#5020
20120149696
2012-06-14

Ethylene diamine modulators of fatty acid hydrolase

#5021
20120149688
2012-06-14

Platelet ADP receptor inhibitors

#5022
20120149573
2012-06-14

Herbicidal pyrimidone derivatives

#5023
20120146014
2012-06-14

Aromatic amine derivatives and organic electroluminescent elements using same

#5024
20120142921
2012-06-07

Substituted hydrazide compounds and use thereof

#5025
20120142711
2012-06-07

Acid-labile trigger units

#5026
20120142695
2012-06-07

Compounds as bradykinin B1 antagonists

#5027
20120142686
2012-06-07

Viral polymerase inhibitors

#5028
20120142677
2012-06-07

Pyrrolidine compounds which modulate the CB2 receptor

#5029
20120142671
2012-06-07

Benzamides and nicotinamides as Syk modulators

#5030
20120142647
2012-06-07

Compounds as respiratory stimulants for treatment of breathing control disorders or diseases

#5031
20120141392
2012-06-07

METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR

#5032
20120136151
2012-05-31

Method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same

#5033
20120136150
2012-05-31

4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use

#5034
20120136147
2012-05-31

Method of hydrolyzing an enzymatic substrate

#5035
20120136025
2012-05-31

Quinolone derivative or pharmaceutically acceptable salt thereof

#5036
20120136018
2012-05-31

Quinolines

#5037
20120135984
2012-05-31

DUAL-ACTION INHBITORS AND METHODS OF USING SAME

#5038
20120135925
2012-05-31

Covalent inhibition of bacterial quorum sensing

#5039
20120130076
2012-05-24

Synthetic multimerizing agents

#5040
20120130069
2012-05-24

Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient

#5041
20120129886
2012-05-24

Metalloenzyme inhibitor compounds

#5042
20120129867
2012-05-24

Inhibitors of protein kinases

#5043
20120129866
2012-05-24

Method for treating a homeostasis-related disease or glaucoma by administering a 1,2,3,4-tetrahyroquinoxaline compound

#5044
20120129844
2012-05-24

N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof

#5045
20120129818
2012-05-24

Compositions and Methods for Treatment of Cardiovascular Disease

#5046
20120123126
2012-05-17

Compounds as c-Met kinase inhibitors

#5047
20120123120
2012-05-17

No-carrier-added nucleophilic [F-18] fluorination of aromatic compounds

#5048
20120123114
2012-05-17

Quinazoline derivatives having tyrosine kinase inhibitory activity

#5049
20120122930
2012-05-17

1H-benzimidazole-5-carboxamides as anti-inflammatory agents

#5050
20120122926
2012-05-17

Biphenyl compounds useful as muscarinic receptor antagonists

#5051
20120122924
2012-05-17

NAMPT INHIBITORS

#5052
20120122923
2012-05-17

DUAL MOLECULES CONTAINING A PEROXIDE DERIVATIVE, THEIR SYNTHESIS AND THERAPEUTIC USES

#5053
20120122868
2012-05-17

Apaf-1 inhibitor compounds

#5054
20120122850
2012-05-17

Biphenyl compounds useful as muscarinic receptor antagonists

#5055
20120122842
2012-05-17

NAMPT and rock inhibitors

#5056
20120122784
2012-05-17

Calcium sensing receptor modulating compounds and pharmaceutical use thereof

#5057
20120121502
2012-05-17

Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof

#5058
20120116091
2012-05-10

Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors

#5059
20120116083
2012-05-10

Heteroaromatic pyrazinoylguanidine sodium channel blockers

#5060
20120115915
2012-05-10

N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation

#5061
20120115907
2012-05-10

NOVEL COMPOUNDS AS INHIBITORS OF RENIN

#5062
20120115902
2012-05-10

3H-imidazo [4, 5-B] pyridine-6-carboxamides as anti-inflammatory agents

#5063
20120115897
2012-05-10

Aryl (ethanoic) propanoic acid ascorbyl ester, preparation method thereof and medicament containing the same

#5064
20120115876
2012-05-10

N-BENZYL-4-METHYLENEAMINO-3-HYDROXY-2-PYRIDONES

#5065
20120115869
2012-05-10

TETRAZOLE DERIVATIVES

#5066
20120115851
2012-05-10

COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME

#5067
20120115850
2012-05-10

Substituted arylamine compounds and methods of treatment

#5068
20120115724
2012-05-10

METHOD OF CONTROLLING UNDESIRED VEGETATION

#5069
20120112174
2012-05-10

Compound for organic optoelectronic device, organic light emitting diode including the same and display device including the organic light emitting diode

#5070
20120108611
2012-05-03

5, 6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists

#5071
20120108605
2012-05-03

-GlcNAc transferase inhibitors and uses thereof

#5072
20120108566
2012-05-03

Nicotinamides as JAK kinase modulators

#5073
20120107273
2012-05-03

NEW PIPERAZINE COMPOUND AND USE THEREOF AS A HCV POLYMERASE INHIBITOR

#5074
20120101287
2012-04-26

Amino-1,3,5-triazines N-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators

#5075
20120101274
2012-04-26

Process for preparing [1-[1-α, 2-α, 3-β(1*,2*) 5-β]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3-1,2,3-triazolo [4,5-] pyrimidin-3-yl]-5-(2-hydroxyethoxy) cyclopentane-1,2-diol and to its intermediates

#5076
20120101105
2012-04-26

Aryl substituted carboxamide derivatives as calcium or sodium channel blockers

#5077
20120101103
2012-04-26

7-phenoxychroman carboxylic acid derivatives

#5078
20120101099
2012-04-26

HISTONE DEACETYLASE INHIBITORS

#5079
20120101091
2012-04-26

VIRAL POLYMERASE INHIBITORS

#5080
20120101079
2012-04-26

Substituted 6-amino-nicotinamides as KCNQ2/3 modulators

#5081
20120097925
2012-04-26

Organic light-emitting device

#5082
20120095075
2012-04-19

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

#5083
20120095012
2012-04-19

TOLUIDINE SULFONAMIDES AND THEIR USE

#5084
20120095000
2012-04-19

Compounds for activating TGF-beta signaling

#5085
20120094997
2012-04-19

Substituted hydroxamic acids and uses thereof

#5086
20120094993
2012-04-19

-pyridin-3-yl or -pyrazin-2-yl carboxamides

#5087
20120094980
2012-04-19

PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING

#5088
20120094977
2012-04-19

Compositions and methods for the treatment of disease associated with TRP-P8 expression

#5089
20120094968
2012-04-19

Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof

#5090
20120094964
2012-04-19

SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS

#5091
20120088911
2012-04-12

Carboxylic acid derivatives, their preparation and use

#5092
20120088783
2012-04-12

Chroman derivatives

#5093
20120088778
2012-04-12

AZOLE DERIVATIVES AND FUSED BICYCLIC AZOLE DERIVATIVES AS THERAPEUTIC AGENTS

#5094
20120088762
2012-04-12

Compounds for enzyme inhibition

#5095
20120088746
2012-04-12

AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME

#5096
20120088241
2012-04-12

Bioreactive agents

#5097
20120083557
2012-04-05

STERICALLY HINDERED AMINE STABILIZERS

#5098
20120083488
2012-04-05

Tetracyclic compound

#5099
20120083483
2012-04-05

Inhibitors of hepatitis C virus replication

#5100
20120082702
2012-04-05

Nicotinamide compounds useful as kinase modulators